Siddhi Wad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Siddhi Wad has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Rahul Purwar
Department of Biosciences and Bioengineering, IIT Bombay, Mumbai, India
13 shared publications - Steven R. Barthel
Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
13 shared publications - Bhavuk Dhamija
Department of Biosciences and Bioengineering, IIT Bombay, Mumbai, India
12 shared publications - Ditipriya Mukherjee
Department of Biosciences and Bioengineering, IIT Bombay, Mumbai, India
12 shared publications - Moumita Basu
Department of Biosciences and Bioengineering, IIT Bombay, Mumbai, India
12 shared publications - Soumitra Marathe
Department of Biosciences and Bioengineering, IIT Bombay, Mumbai, India
12 shared publications
Latest Publications
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Supplementary Table S2. List of HIF-1α pathway proteins induced in CoCl2-treated, pseudohypoxic Jurkat T-cells based on global proteomics analysis
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Supplementary Table S2. List of HIF-1α pathway proteins induced in CoCl2-treated, pseudohypoxic Jurkat T-cells based on global proteomics analysis
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
MTT assay data showing Echinomycin treatment does not markedly alter cell viability
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
MTT assay data showing Echinomycin treatment does not markedly alter cell viability
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Quadruple Immunofluorescence staining of healthy unactivated T-cells showing IL-9R, IL-2RG, CD3 and DAPI levels and STRING network analysis showing HIF-1α pathway associated proteins enriched by CoCl2 treatment in Jurkat cells.
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Quadruple Immunofluorescence staining of healthy unactivated T-cells showing IL-9R, IL-2RG, CD3 and DAPI levels and STRING network analysis showing HIF-1α pathway associated proteins enriched by CoCl2 treatment in Jurkat cells.
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Data from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Cutaneous T-cell lymphoma (CTCL) is a multistage disease characterized by rapid dissemination of malignant T lymphocytes from skin lesions to visceral organs and bone marrow. The cytokine IL-9 and its receptor (IL-9R) are aberrantly overexpressed in CTCL lesions and function to enhance tumor cell survival. In this study, we uncovered a critical new role for IL-9 as a potent inducer of migration of malignant T cells. Stimulation of IL-9R–expressing T-cell lymphoma cells with IL-9 induced a pseudohypoxic cellular state by elevating downstream levels of the promigratory and oxygen-sensing transcription factor hypoxia-inducible factor (HIF)-1α. High-throughput quantitative proteomic analyses of pseudohypoxic malignant T cells identified the actin-modulating protein cofilin-1 (CFL-1) as a promigratory CTCL-intrinsic target downstream of IL-9–HIF-1α signaling. Consistently, multicolor immunofluorescence staining revealed marked coexpression of CFL-1 with HIF-1α in both IL-9–treated human lymphoma cell lines and in patient CTCL skin biopsies compared with normal controls. Genetic knockdown of IL9R or HIF1A in human T-cell lymphoma lines by RNAi significantly reduced both HIF-1α and CFL-1 coexpression and reversed IL-9–induced migration. Finally, pharmacologic antagonism of HIF-1α activity using the FDA-designated orphan drug echinomycin significantly abrogated IL-9–triggered migration of both malignant T-cell lines and patient-derived T-cell lymphoma cells from CTCL biospecimens.Implications:Our results uncover a CTCL-intrinsic IL-9–HIF-1α–CFL-1 axis as a critical promoter of malignant T-cell migration. They further identify HIF-1α and CFL-1 as promising therapeutic targets to mitigate IL-9–induced CTCL dissemination.
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Cutaneous T-cell lymphoma (CTCL) is a multistage disease characterized by rapid dissemination of malignant T lymphocytes from skin lesions to visceral organs and bone marrow. The cytokine IL-9 and its receptor (IL-9R) are aberrantly overexpressed in CTCL lesions and function to enhance tumor cell survival. In this study, we uncovered a critical new role for IL-9 as a potent inducer of migration of malignant T cells. Stimulation of IL-9R–expressing T-cell lymphoma cells with IL-9 induced a pseudohypoxic cellular state by elevating downstream levels of the promigratory and oxygen-sensing transcription factor hypoxia-inducible factor (HIF)-1α. High-throughput quantitative proteomic analyses of pseudohypoxic malignant T cells identified the actin-modulating protein cofilin-1 (CFL-1) as a promigratory CTCL-intrinsic target downstream of IL-9–HIF-1α signaling. Consistently, multicolor immunofluorescence staining revealed marked coexpression of CFL-1 with HIF-1α in both IL-9–treated human lymphoma cell lines and in patient CTCL skin biopsies compared with normal controls. Genetic knockdown of IL9R or HIF1A in human T-cell lymphoma lines by RNAi significantly reduced both HIF-1α and CFL-1 coexpression and reversed IL-9–induced migration. Finally, pharmacologic antagonism of HIF-1α activity using the FDA-designated orphan drug echinomycin significantly abrogated IL-9–triggered migration of both malignant T-cell lines and patient-derived T-cell lymphoma cells from CTCL biospecimens.Implications:Our results uncover a CTCL-intrinsic IL-9–HIF-1α–CFL-1 axis as a critical promoter of malignant T-cell migration. They further identify HIF-1α and CFL-1 as promising therapeutic targets to mitigate IL-9–induced CTCL dissemination.
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Cancer Dependency Map (DepMap) analysis of gene effects from HIF1A or CFL1 knockout in malignant T-cell and diverse non-T-cell lines.
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Cancer Dependency Map (DepMap) analysis of gene effects from HIF1A or CFL1 knockout in malignant T-cell and diverse non-T-cell lines.
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure Legends from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Legends of Supplementary Figures S1-S6
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure Legends from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Legends of Supplementary Figures S1-S6
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Western blotting data showing differential expression of HIF-1α due to IL9R knockdown or overexpression in malignant T-cells.
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Western blotting data showing differential expression of HIF-1α due to IL9R knockdown or overexpression in malignant T-cells.
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Cell viability and Apoptosis Assays showing short-term IL-9 treatment or HIF1α knockdown does not markedly alter malignant T-cell viability.
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Cell viability and Apoptosis Assays showing short-term IL-9 treatment or HIF1α knockdown does not markedly alter malignant T-cell viability.
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
3D videomicroscopy data showing inhibition of HIF-1α by Echinomycin reverses IL-9-stimulated migration of activated primary T-cells.
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
3D videomicroscopy data showing inhibition of HIF-1α by Echinomycin reverses IL-9-stimulated migration of activated primary T-cells.
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Table S1. Details of enrolled patients with CTCL and other lymphomas.
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
Table S1. Details of enrolled patients with CTCL and other lymphomas.